Key result
Hyperaldosteronism in resistant hypertensive patients was associated with significantly higher 24-hour ambulatory blood pressure levels despite similar mean office blood pressures (160.0/89.4 mmHg).
Why the study?
Does hyperaldosteronism increase 24-h ambulatory blood pressure levels in patients with resistant hypertension?
Observational (n=251)
Does hyperaldosteronism increase 24-h ambulatory blood pressure levels in patients with resistant hypertension?
In patients with resistant hypertension, hyperaldosteronism is associated with higher 24-hour ambulatory blood pressure despite similar office blood pressure, suggesting higher cardiovascular risk.
Office BP may underestimate risk in resistant hypertension with hyperaldosteronism; leaves open whether ABPM-guided screening improves outcomes.
BACKGROUND: Aldosterone excess has been reported to be a common cause of resistant hypertension. To what degree this represents true treatment resistance is unknown. OBJECTIVE: The present study aimed to compare the 24-h ambulatory blood pressure monitoring (ABPM) levels in resistant hypertensive patients with or without hyperaldosteronism. METHODS: Two hundred and fifty-one patients with resistant hypertension were prospectively evaluated with an early-morning plasma renin activity (PRA), 24-h urinary aldosterone and sodium, and 24-h ABPM. Daytime, night-time, and 24-h blood pressure (BP) and nocturnal BP decline were determined. Hyperaldosteronism (H-Aldo) was defined as suppressed PRA (<1.0 ng/ml per h or <1.0 mug/l per h) and elevated 24-h urinary aldosterone excretion (>/= 12 mug/24-h or >/= 33.2 nmol/day) during ingestion of the patient's routine diet. RESULTS: In all patients, the mean office BP was 160.0 +/- 25.2/89.4 +/- 15.3 mmHg on an average of 4.2 medications. There was no difference in mean office BP between H-Aldo and normal aldosterone status (N-Aldo) patients. Daytime, night-time, and 24-h systolic and diastolic BP were significantly higher in H-Aldo compared to N-Aldo males. Daytime, night-time, and 24-h systolic BP were significantly higher in H-Aldo compared to N-Aldo females. Multivariate analysis indicated a significant interaction between age and aldosterone status such that the effects of aldosterone on ambulatory BP levels were more pronounced with increasing age. CONCLUSIONS: In spite of similar office BP, ABPM levels were higher in resistant hypertensive patients with H-Aldo. These results suggest that high aldosterone levels impart increased cardiovascular risk not reflected by office BP measurements.
No takes yet. Share an insight, caveat, or question.
Pimenta et al. (2007) conducted an observational in Resistant hypertension (n=251). Hyperaldosteronism vs. Normal aldosterone status was evaluated on 24-h ambulatory blood pressure monitoring (ABPM) levels. Hyperaldosteronism in resistant hypertensive patients was associated with significantly higher 24-hour ambulatory blood pressure levels despite similar mean office blood pressures (160.0/89.4 mmHg).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: